facebook_pixel
Equity Strategy 16 October 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Taiwan Semiconductor: Buy. Wins Contract To Make Second Processor For IPad

Taiwan Semiconductor: Buy. Wins Contract To Make Second Processor For IPad

* Taiwan Semiconductor Manufacturing Company Limited (TSMC) is engaged in manufacturing, selling, packaging, testing, and computer-aided designing integrated circuits and other semiconductor devices. It also manufactures masks. The company is involved in researching, developing, designing, manufacturing, and selling solid state lighting devices and related applications products and systems, as well as renewable energy and saving related […]

FIND OUT MORE

Equity Strategy 15 October 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
American Airlines: Buy. Uptrend Starting

American Airlines: Buy. Uptrend Starting

* Profile: American Airlines Group Inc., through its subsidiaries, operates in the airline industry. As of July 8, 2014, it operated an average of approximately 6,700 flights per day to approximately 339 destinations in 54 countries from its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. The company […]

FIND OUT MORE

Equity Strategy 14 October 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Wells Fargo: Hold. 3Q Net Income Rises 2.7% To $5.73B

Wells Fargo: Hold. 3Q Net Income Rises 2.7% To $5.73B

* As early as 20 March 2014, we advised to Buy Wells Fargo. Target: $55: http://www.bluephoenixfinancials.com/equity-strategies/wells-fargo-buy-second-phase-uptrend-started/ * On 19 Sep 2014, Wells Fargo traded as high as $53.80, just below our $55.00 target price * Since then, Wells Fargo has dropped and is at the time of this writing trading at $49.38 * We advice Investors […]

FIND OUT MORE

Equity Strategy 14 October 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
Biogen Idec: Buy Before 3Q Earnings On Oct 22

Biogen Idec: Buy Before 3Q Earnings On Oct 22

* NOTE: This is a High Risk Equity Strategy Only For Investors who Can Afford Price Risk & Volatility * Profile: Biogen Idec discovers, develops, manufactures, and markets therapies for the treatment of multiple sclerosis or MS, neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Products include Tecfidera, Avonex and Tysabri […]

FIND OUT MORE

Equity Strategy 14 October 2014
BLUE PHOENIX FINANCIALS PREMIUM CONTENT Not a member? Join Now!
JPMorgan: Hold. 3Q Earnings Miss Estimates

JPMorgan: Hold. 3Q Earnings Miss Estimates

* As early as 20 Mar 2014, we advised to Buy JPMorgan. Target: $67.00:  http://www.bluephoenixfinancials.com/equity-strategies/jpmorgan-buy-second-phase-uptrend-started/ * On 15 July 2914, we advised to Hold Long Positions when 2Q Profit Beat Estimates: http://www.bluephoenixfinancials.com/equity-strategies/jpmorgan-hold-long-positions-2q-profit-beats-estimates/ * JP Morgan 3Q earnings have missed estimates. We now advise Investors to continue to hold their long positions and to wait for fresh catalysts […]

FIND OUT MORE